Maria Dall'Era, MD
She is the co-chair of the Steering Committee for the Lupus Clinical Investigators Network (LuCIN).
Dr. Dall’Era plays a large role in the education of trainees, both in the outpatient clinical arena, inpatient setting, and in the medical school. With a grant from the American College of Rheumatology’s Lupus Initiative, she created two pilot, interactive, on-line, virtual simulation SLE cases in collaboration with Dr. Michelle Lin. She incorporated novel features into the cases including a “differential diagnosis slider” in which the learner is required to re-adjust their differential diagnosis after case content is revealed. With a clinician scholar award grant from the American College of Rheumatology, she developed an interactive mobile app called PIVOT to teach clinical reasoning in rheumatology.
Dr. Dall’Era is also active in the education of practicing physicians and lectures frequently on the topic of lupus at national conferences and review courses.
Dall'Era M, Bruce IN, Gordon C, Manzi S, McCaffrey J, Lipsky PE. Current challenges in the development of new treatments for lupus. 2019. PMID: 30636212
Dall'Era M. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. 2011. PMID: 21720247
Dall'era M, Chakravarty EF. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. 2011. PMID: 21584692
Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Volume 63 of Issue 3. 2010. PMID: 21080348
Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Volume 56 of Issue 12. 2007. PMID: 18050206